hydralazine has been researched along with Cushing Syndrome in 2 studies
Hydralazine: A direct-acting vasodilator that is used as an antihypertensive agent.
hydralazine : The 1-hydrazino derivative of phthalazine; a direct-acting vasodilator that is used as an antihypertensive agent.
Cushing Syndrome: A condition caused by prolonged exposure to excess levels of cortisol (HYDROCORTISONE) or other GLUCOCORTICOIDS from endogenous or exogenous sources. It is characterized by upper body OBESITY; OSTEOPOROSIS; HYPERTENSION; DIABETES MELLITUS; HIRSUTISM; AMENORRHEA; and excess body fluid. Endogenous Cushing syndrome or spontaneous hypercortisolism is divided into two groups, those due to an excess of ADRENOCORTICOTROPIN and those that are ACTH-independent.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kaufmann, W | 1 |
2 other studies available for hydralazine and Cushing Syndrome
| Article | Year |
|---|---|
[Principles of hypertension therapy].
Topics: Adult; Antihypertensive Agents; Aortic Valve Stenosis; Brain Neoplasms; Cushing Syndrome; Diagnosis, | 1967 |
Clinical rounds from the Massachusetts General Hospital. Childhood hypertension: etiology, investigation and treatment.
Topics: Adolescent; Adrenal Gland Neoplasms; Aortic Coarctation; Child; Child, Preschool; Cushing Syndrome; | 1966 |